Myrexis, Inc. (Formerly Known as Myriad Pharmaceuticals, Inc.) to Hold Conference Call to Discuss Fiscal Third Quarter 2011 Financial Results

SALT LAKE CITY, April 28, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced it will hold a conference call on Tuesday, May 10, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to discuss financial results for its fiscal third quarter 2011 ended March 31, 2011.